87 cases · page 3 of 3
Showing 61–86HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P v.LAMA FRANCE
1 Division Locale de Paris UPC_CFI_358/2023 Décision au fond du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 13/11/2024 ABSTRACT : 1. Conformément à l'article 69 de la Convention sur les brevets européens (CBE) et du Protocole sur son interprétation, la présente Cour
Abbott Diabetes Care Inc. v.Respondent
1 Paris Local Division UPC_CFI_395/2023 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 11/10/2024 APPLICANTS 1) Abbott Logistics B.V. Postbus 365 8000AJ Zwolle – NL Represented by Christian Dekoninck 2) 3) Abbott Diagnostics GmbH Max-Planck-Ring 2 65205 Wies
Unilever France v.Respondent
1 Paris local Division UPC_CFI_494/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 24/09/2024 REQUERANT (DEFENDEUR dans la procédure principale) Unilever France 20 rue des Deux Gares - 92500 - Rueil Malmaison CEDEX - FR Rep
HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P v.Respondent
1 Division locale de Paris UPC_CFI_358/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 27/08/2024 concernant une demande d’audition de témoin à l’audience orale (R.176 et 177 RdP) ABSTRACT : 1. Les questions orales posées au témoin, auteur
HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P v.LAMA FRANCE
1 Division locale de Paris UPC_CFI_358/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 21/08/2024 DEMANDEUR HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P 10300 Energy Drive, Spring, Harris County, TX, 77389, USA - 77389 - Harris County - US Rep
HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P v.LAMA FRANCE
1 Division locale de Paris UPC_CFI_358/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 02/08/2024 concernant R.191 RdP DEMANDEUR HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P 10300 Energy Drive, Spring, Harris County, TX, 77389, USA - 77389 - H
Dexcom France SAS, Dexcom Inc., Dexcom International Limited, Abbott Diabetes Care Inc. v.Abbott Diabetes Care Inc.
1 Paris Local Division UPC_CFI_425/2023 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 31/07/2024 concerning R. 191 RoP APPLICANT 1) Abbott Diabetes Care Inc. 1360 South Loop Road 94502 - Alameda - US Represented by Christian Dekoninck RESPONDENTS 1) Dexcom
CANÈ S.p.A. v.FRANCE DÉVELOPPEMENT ÉLECTRONIQUE
1 Paris Local Division UPC_CFI_419/2023 Décision au fond du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 26/07/2024 DEMANDEUR 1) CANÈ S.p.A. Via Cuorgnè 42/A 10098 - Rivoli (TO) - IT Représenté par Konstantin Schallmoser DÉFENDEUR 1) FRANCE DÉVELOPPEMENT ÉLECTRONIQUE
Seoul Viosys Co., Ltd v.Laser Components SAS, Photon Wave Co.,Ltd.
1 Division locale de Paris UPC_CFI_440/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 24/07/2024 DEMANDEUR Seoul Viosys Co., Ltd Représenté par Pauline Debré 65-16, Sandan-ro 163 beon-gil, Danwon-gu - 15429 - Ansan-si, Gyeonggi-do - Répub
DexCom, Inc. v.Abbott Scandinavia Aktiebolag, Abbott NV / SA, Abbott S.r.l., Abbott Diabetes Care Inc., Abbott Diagnostics GmbH, Abbott France, Abbott B.V., Abbott Logistics B.V., Abbott GmbH, Abbott Laboratories
DexCom, Inc. brought an infringement action against multiple Abbott entities concerning European Patent EP3435866, which relates to an analyte monitoring system (continuous glucose monitoring technology). The defendants filed a counterclaim for revocation of the patent. The Paris Local Division addressed jurisdictional questions regarding the scope of dispute, the applicability of the Brussels Ibis Regulation, and the validity of the patent, finding novelty and no added subject-matter, but concluding that the claimed invention lacked inventive step.
Arm Germany GmbH, ARM Limited, Allinea Software GmbH, Simulity Labs Limited, Arm lreland Limited, Arm Sweden AB, SVF Holdco, Arm France SAS, Arm Germany d.o.o, Apical Limited v.Respondent
The provided document contains only metadata indicating approval signatures and timestamps dated 20–21 May 2024, with the phrase 'Hyväksyn dokumentin' (Finnish for 'I approve the document'). No substantive judgment text, facts, legal arguments, or operative decision is available in the source material.
Seoul Viosys Co., Ltd v.Photon Wave Co.,Ltd., Laser Components SAS
L’intervenant ne peut développer des prétentions contraires à la partie qu’il soutient et ne peut développer de manière autonome des demandes et selon des modalités procédurales distinctes de celles offertes à la partie qu’elle soutient. Dès lors, l’intervenant n’ayant pas déposé de demande reconventionnelle en nullité dans le délai imparti à la personne qu’il soutient, ne peut pas prétendre à une extension des délais pour déposer une demande autonome. Même si le brevet européen en litige a été
SVF Holdco v.ICPillar LLC
In the case of multiple defendants, if one of the defendants has its residence within the territory of the Local Division seized, Article 33(1)(b) UPCA must be applied, regardless of whether the other defendants are based inside or outside the Contracting Member States or inside or outside the EU. Hence the only requirements to be met are: 1) the multiple defendants have a commercial relationship, 2) the action relates to the same alleged infringement. The requirement of a “commercial relationsh
NOVAWELL v.C-KORE SYSTEMS LIMITED
1 Paris Local Division UPC_CFI_397/2023 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 26/03/2024 APPLICANT: C-KORE SYSTEMS LIMITED 3 Bramley's Barn The Menagerie, Skipwith Road - YO19 6ET - Escrick - GB Represented by Denis Schertenleib RESPONDENT: NOVAWELL
Laser Components SAS v.Respondent
1 Division locale de Paris UPC_CFI_440/2023 Ordonnance procédurale du Tribunal de première instance de la Juridiction unifiée du brevet rendue le 13/03/2024 DEMANDEUR: Laser Components SAS 45B Route des Gardes 92190 Meudon - FR Representé par Helge von Hirschhausen DEFENDEUR: Seoul Viosys Co., Ltd 6
C-KORE SYSTEMS LIMITED v.NOVAWELL
This procedural order concerns a review request filed by Novawell against an ex parte saisie order granted to C-Kore Systems Limited, the proprietor of European patent EP 2 265 793 relating to subsea apparatus and testing. The Court examined whether Novawell's review request was filed within the 30-day time limit under Rule 197.3 of the Rules of Procedure, addressing when the 'execution of the measures' begins for purposes of calculating that deadline. The Court also considered the criteria for granting the ex parte order, the distinction between preserving evidence and inspection procedures, and the conformity of the saisie carried out by an expert assisted by a bailiff with French national law.
ICPillar LLC v.Respondent
1 Paris Local Division UPC_CFI_495/2023 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 28/02/2024 APPLICANT ICPillar LLC 4265 San Felipe Street, Suite 1100 77027 - Houston, Texas - US Represented by Lionel Martin RELEVANT OTHER PARTIES ARM Limited 110 Fulbou
Seoul Viosys Co., Ltd v.Laser Components SAS
1 Division locale de Paris UPC_CFI_440/2023 Ordonnance du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 27/02/2024 DEMANDEUR : 1) Seoul Viosys Co., Ltd 65-16, Sandan-ro 163beon-gil, Danwon-gu - 15429 - Ansan-si, Gyeonggi-do - KR Représenté par Pauline Debré DÉFENDEUR :
Abbott Diabetes Care Inc. v.Dexcom Inc., Dexcom France SAS, Dexcom International Limited
This procedural order concerns an infringement action brought by Abbott Diabetes Care Inc. against three Dexcom entities before the Paris Local Division. The order addresses service difficulties, particularly with Dexcom International Limited in Ireland, and aligns the deadlines for filing the Statement of Defence for all three defendants. The Judge-Rapporteur approved the parties' agreed reasonable extension, setting the starting point for all defendants at 15/01/2024, with the Statement of Defence expected by 15/04/2024.
SAS LASER COMPONENTS v.Seoul Viosys Co., Ltd
In this legal proceeding before Paris (FR) Local Division (decision issued on 2024-02-12) under reference UPC-001614, SAS LASER COMPONENTS appeared in dispute with Seoul Viosys Co., Ltd concerning patent rights and legal remedies.
ICPillar LLC v.Respondent
ICPillar LLC, proprietor of European Patent EP3000239, brought an infringement action against twelve defendants of the ARM group of companies. When standard service methods failed—particularly delivery to Arm Poland Sp. z.o.o. in Poland—the Claimant sought authorization under Rule 275.1 of the Rules of Procedure for alternative methods of service. The Court authorized alternative service only to the extent that the original methods had failed, rejecting the proposed method that merely replicated the already-attempted registered letter approach, and clarified the application of the ten-day delay rule under the Hague Service Convention.
ICPillar LLC v.ARM Limited Apical Limited Arm Poland Sp. z.o.o Simulity Labs Limited Hyperglance limited SVF Holdco
In this legal proceeding before Paris (FR) Local Division (decision issued on 2024-02-12) under reference UPC-001612, ICPillar LLC appeared in dispute with ARM Limited Apical Limited Arm Poland Sp. z.o.o Simulity Labs Limited Hyperglance limited SVF Holdco concerning patent rights and legal remedies.
DexCom, Inc. v.Abbott Scandinavia Aktiebolag, Newyu,Inc., Abbott Laboratories, Abbott, Abbott B.V., Abbott Oy, Abbott Diagnostics GmbH, Abbott Gesellschaft m.b.H., Abbott S.r.l., Abbott France, Abbott GmbH, Abbott Laboratories A/S, Abbott Diabetes Care Inc., Abbott
This procedural order concerns an infringement action brought by DexCom, Inc. against fourteen defendants, including multiple Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The dispute centered on the alignment of deadlines for filing the Statement of Defence (SoD) across all defendants, given that service on some defendants was delayed or still in progress. Following a case management meeting where all parties orally agreed on a reasonable extension date, the Judge-Rapporteur ordered that the time limit for filing the SoD be aligned for all defendants, with the starting point set at 15 December 2023 and the SoD expected by 15 March 2024.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
This is a procedural order from the Paris Local Division concerning an infringement action brought by DexCom, Inc. against fourteen defendants, primarily comprising various Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The order addresses service difficulties and aligns the deadline for filing the Statement of Defence across all defendants. The Judge-Rapporteur accepted the parties' agreed extension, setting the Statement of Defence deadline to 15 March 2024, with the starting point aligned to 15 December 2023.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
This is a procedural order from the Paris Local Division concerning an infringement action brought by DexCom, Inc. against fourteen defendants, primarily comprising various Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The order addresses service difficulties and aligns the deadline for filing the Statement of Defence across all defendants. The Judge-Rapporteur accepted the parties' agreed extension, setting the Statement of Defence deadline to 15 March 2024, with the starting point aligned to 15 December 2023.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
This is a procedural order from the Paris Local Division concerning an infringement action brought by DexCom, Inc. against fourteen defendants, primarily comprising various Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The order addresses service difficulties and aligns the deadline for filing the Statement of Defence across all defendants. The Judge-Rapporteur accepted the parties' agreed extension, setting the Statement of Defence deadline to 15 March 2024, with the starting point aligned to 15 December 2023.
HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P v.LAMA FRANCE
1 Division locale de Paris UPC_CFI_358/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 02/08/2024 concernant R.191 RdP DEMANDEUR HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P 10300 Energy Drive, Spring, Harris County, TX, 77389, USA - 77389 - H
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.